Published in Toxicol Sci on February 01, 2010
Ultrasensitive response motifs: basic amplifiers in molecular signalling networks. Open Biol (2013) 1.16
The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci (2010) 1.00
Changes in DNA methylation and gene expression during 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced suppression of the lipopolysaccharide-stimulated IgM response in splenocytes. Toxicol Sci (2011) 0.85
Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. Front Physiol (2012) 0.84
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation. Drug Metab Dispos (2015) 0.83
Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin. BMC Syst Biol (2010) 0.83
Molecular signaling network motifs provide a mechanistic basis for cellular threshold responses. Environ Health Perspect (2014) 0.82
B cell activation triggered by the formation of the small receptor cluster: a computational study. PLoS Comput Biol (2011) 0.80
All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2013) 0.78
Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion. BMC Pharmacol Toxicol (2014) 0.76
The Influence of Human Interindividual Variability on the Low-Dose Region of Dose-Response Curve Induced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Primary B Cells. Toxicol Sci (2016) 0.75
A Network Model to Describe the Terminal Differentiation of B Cells. PLoS Comput Biol (2016) 0.75
Core transcriptional regulatory circuitry in human embryonic stem cells. Cell (2005) 34.93
Construction of a genetic toggle switch in Escherichia coli. Nature (2000) 24.02
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76
Mammalian MAP kinase signalling cascades. Nature (2001) 18.89
Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet (2005) 14.39
Hematopoiesis: an evolving paradigm for stem cell biology. Cell (2008) 11.95
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell (2008) 10.68
AP-1 as a regulator of cell life and death. Nat Cell Biol (2002) 10.10
Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72
Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol (2002) 9.17
Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol (2003) 8.91
TLR signaling. Semin Immunol (2007) 8.16
Multistability in the lactose utilization network of Escherichia coli. Nature (2004) 7.71
Stepwise reprogramming of B cells into macrophages. Cell (2004) 7.68
Positive feedback in eukaryotic gene networks: cell differentiation by graded to binary response conversion. EMBO J (2001) 7.03
How is pluripotency determined and maintained? Development (2007) 6.92
Interlinked fast and slow positive feedback loops drive reliable cell decisions. Science (2005) 6.88
LPS/TLR4 signal transduction pathway. Cytokine (2008) 6.60
2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol (1982) 6.48
Teleonomic mechanisms in cellular metabolism, growth, and differentiation. Cold Spring Harb Symp Quant Biol (1961) 6.43
Humoral immunity due to long-lived plasma cells. Immunity (1998) 6.35
Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity (2002) 6.27
A positive-feedback-based bistable 'memory module' that governs a cell fate decision. Nature (2003) 6.25
Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity (2003) 5.95
Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature (2007) 5.39
Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems. Proc Natl Acad Sci U S A (2004) 4.63
Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell (1994) 4.60
Network dynamics and cell physiology. Nat Rev Mol Cell Biol (2001) 4.22
Regulation of plasma-cell development. Nat Rev Immunol (2005) 3.98
The search for endogenous activators of the aryl hydrocarbon receptor. Chem Res Toxicol (2007) 3.68
Ah receptor signaling pathways. Annu Rev Cell Dev Biol (1996) 3.60
Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev Biol (2007) 3.49
Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. Chaos (2001) 3.48
Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity (2006) 3.41
PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol (2004) 3.39
Stochastic modelling for quantitative description of heterogeneous biological systems. Nat Rev Genet (2009) 3.27
MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell (2004) 3.12
Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science (1997) 2.93
Bistability in the JNK cascade. Curr Biol (2001) 2.93
Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation. J Immunol (2004) 2.90
Active repression mechanisms of eukaryotic transcription repressors. Trends Genet (1996) 2.75
Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells. Immunity (2006) 2.64
Survival of long-lived plasma cells is independent of antigen. Int Immunol (1998) 2.45
Regulation of the eukaryotic cell cycle: molecular antagonism, hysteresis, and irreversible transitions. J Theor Biol (2001) 2.42
Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev Immunol (2001) 2.32
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology (2009) 2.31
Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol (2000) 2.24
Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol (2002) 2.24
The dynamics of cell cycle regulation. Bioessays (2002) 2.21
The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect (1994) 2.16
Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol (1998) 2.10
PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev (1999) 2.09
Transcriptional dynamics of the embryonic stem cell switch. PLoS Comput Biol (2006) 2.06
Aryl hydrocarbon receptor-mediated signal transduction. Crit Rev Toxicol (1997) 2.00
Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J (1998) 1.96
To be or not to be active: the stochastic nature of enhancer action. Bioessays (2000) 1.88
Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med (2000) 1.87
Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J (2000) 1.79
Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity (2001) 1.78
Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. J Immunol (2002) 1.77
BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol (2000) 1.76
Loss of Pax5 promotes plasma cell differentiation. Immunity (2006) 1.76
Plasma cells: finding new light at the end of B cell development. Nat Immunol (2001) 1.74
Agent-based models in translational systems biology. Wiley Interdiscip Rev Syst Biol Med (2010) 1.70
Feedback regulation of opposing enzymes generates robust, all-or-none bistable responses. Curr Biol (2008) 1.57
Multistable and multistep dynamics in neutrophil differentiation. BMC Cell Biol (2006) 1.56
Evolving views on the genealogy of B cells. Nat Rev Immunol (2008) 1.52
Towards an understanding of lineage specification in hematopoietic stem cells: a mathematical model for the interaction of transcription factors GATA-1 and PU.1. J Theor Biol (2006) 1.52
Computational modeling of the hematopoietic erythroid-myeloid switch reveals insights into cooperativity, priming, and irreversibility. PLoS Comput Biol (2009) 1.48
How mammalian transcriptional repressors work. Eur J Biochem (2004) 1.46
Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression. Toxicol Appl Pharmacol (2001) 1.43
In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation. Immunity (1997) 1.38
A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. J Immunol (2005) 1.37
How regulated protein translocation can produce switch-like responses. Trends Biochem Sci (1998) 1.35
Coupled feedback loops form dynamic motifs of cellular networks. Biophys J (2007) 1.32
Germinal center reaction. Curr Opin Hematol (2001) 1.29
Developmental plasticity of lymphocytes. Curr Opin Immunol (2008) 1.29
A review of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced changes in immunocompetence: 1991 update. Toxicology (1991) 1.25
Modular nature of Blimp-1 in the regulation of gene expression during B cell maturation. J Immunol (2004) 1.24
Transcriptional regulatory cascades controlling plasma cell differentiation. Immunol Rev (2003) 1.19
An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity (1996) 1.18
Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte. Immunopharmacology (1989) 1.13
Bistable switches control memory and plasticity in cellular differentiation. Proc Natl Acad Sci U S A (2009) 1.13
Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells. Mol Pharmacol (1998) 1.12
Constitutive activation and environmental chemical induction of the aryl hydrocarbon receptor/transcription factor in activated human B lymphocytes. Mol Pharmacol (2005) 1.12
Architecture and dynamics of the transcription factor network that regulates B-to-plasma cell differentiation. J Biochem (2007) 1.11
Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. J Pharmacol Exp Ther (2000) 1.09
Plasma cell differentiation and multiple myeloma. Curr Opin Immunol (2004) 1.08
Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab')2-co-stimulated B lymphocytes. Eur J Immunol (1996) 1.07
Modelling the fission yeast cell cycle. Brief Funct Genomic Proteomic (2004) 1.02
2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a. J Pharmacol Exp Ther (2008) 0.98
The toxicologic hazard of superfund hazardous-waste sites. Rev Environ Health (1998) 0.98
Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells. Toxicol Appl Pharmacol (2002) 0.98
Positive receptor feedback during lineage commitment can generate ultrasensitivity to ligand and confer robustness to a bistable switch. Biophys J (2008) 0.97
A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes. Immunology (2002) 0.97
Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2). Proc Natl Acad Sci U S A (1996) 0.96
Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells. Toxicol Sci (2009) 0.94
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Toxicol Sci (2003) 0.94
Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin evaluated with a multicompartment geometric model of hepatic zonation. Toxicol Appl Pharmacol (1997) 0.93
Human BSAP and BLIMP1 conform an autoregulatory feedback loop. Blood (2007) 0.92
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522. J Clin Oncol (2014) 5.80
Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal (2008) 5.57
Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell (2007) 5.49
Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell (2008) 5.04
Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science (2013) 4.94
Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature (2011) 3.19
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol (2012) 3.18
Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol (2012) 3.04
The use and interpretation of competing risks regression models. Clin Cancer Res (2012) 3.01
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol (2013) 3.00
The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol (2011) 2.98
Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med (2012) 2.90
Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater (2009) 2.85
Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nanotechnol (2009) 2.78
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. J Immunol (2007) 2.69
Groundwater arsenic contamination throughout China. Science (2013) 2.64
Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med (2004) 2.64
The HIV epidemic in Yunnan Province, China, 1989-2007. J Acquir Immune Defic Syndr (2010) 2.61
Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes (2007) 2.59
Genome-scale functional profiling of the mammalian AP-1 signaling pathway. Proc Natl Acad Sci U S A (2003) 2.45
Controlling the synthesis and assembly of silver nanostructures for plasmonic applications. Chem Rev (2011) 2.40
Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol (2007) 2.37
Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34
In vivo molecular photoacoustic tomography of melanomas targeted by bioconjugated gold nanocages. ACS Nano (2010) 2.29
Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol (2009) 2.19
Energy policy: A low-carbon road map for China. Nature (2013) 2.18
Patellar resurfacing versus nonresurfacing in total knee arthroplasty: a meta-analysis of randomised controlled trials. Int Orthop (2013) 2.13
Corneal immunity is mediated by heterogeneous population of antigen-presenting cells. J Leukoc Biol (2003) 2.08
The corneal stroma is endowed with a significant number of resident dendritic cells. Invest Ophthalmol Vis Sci (2003) 2.05
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res (2010) 2.04
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial. Lancet Oncol (2011) 2.03
Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment. Toxicol Sci (2011) 2.03
Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature (2010) 2.02
The extended distally based sural neurocutaneous flap for foot and ankle reconstruction: a retrospective review of 10 years of experience. Ann Plast Surg (2014) 2.00
Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res (2003) 1.98
Gold nanocages as photothermal transducers for cancer treatment. Small (2010) 1.92
De novo assembly and characterisation of the transcriptome during seed development, and generation of genic-SSR markers in peanut (Arachis hypogaea L.). BMC Genomics (2012) 1.90
Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol (2011) 1.86
Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure (2008) 1.86
A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol Sci (2012) 1.81
Novel characterization of MHC class II-negative population of resident corneal Langerhans cell-type dendritic cells. Invest Ophthalmol Vis Sci (2002) 1.80
Gold nanocages: from synthesis to theranostic applications. Acc Chem Res (2011) 1.80
Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J Exp Med (2002) 1.79
Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (2012) 1.77
Reduction of transient signal oscillations in true-FISP using a linear flip angle series magnetization preparation. Magn Reson Med (2003) 1.73
China's international trade and air pollution in the United States. Proc Natl Acad Sci U S A (2014) 1.66
ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol (2009) 1.63
Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer (2008) 1.63
St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis. Toxicol Appl Pharmacol (2006) 1.60
Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. J Am Chem Soc (2008) 1.56
Solution structure of the MAPK phosphatase PAC-1 catalytic domain. Insights into substrate-induced enzymatic activation of MKP. Structure (2003) 1.54
In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. Int J Pharm (2012) 1.54
CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry (2006) 1.54
Automated rectilinear self-gated cardiac cine imaging. Magn Reson Med (2004) 1.52
Genetic evolution of swine influenza A (H3N2) viruses in China from 1970 to 2006. J Clin Microbiol (2008) 1.52
Satellite-Based Spatiotemporal Trends in PM2.5 Concentrations: China, 2004-2013. Environ Health Perspect (2015) 1.51
Projections of global mercury emissions in 2050. Environ Sci Technol (2009) 1.51
Genomic signatures and dose-dependent transitions in nasal epithelial responses to inhaled formaldehyde in the rat. Toxicol Sci (2008) 1.51
The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small (2010) 1.50
Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival. Mol Biosyst (2006) 1.47
Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect (2010) 1.47
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene. Crit Rev Toxicol (2004) 1.45
Physiological modeling of inhalation kinetics of octamethylcyclotetrasiloxane in humans during rest and exercise. Toxicol Sci (2003) 1.44
Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. J Biol Chem (2011) 1.43
EDGE: a centralized resource for the comparison, analysis, and distribution of toxicogenomic information. Mol Pharmacol (2005) 1.43
Alterations in corneal stromal dendritic cell phenotype and distribution in inflammation. Arch Ophthalmol (2003) 1.43
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci (2009) 1.42
Statistical analysis of nonmonotonic dose-response relationships: research design and analysis of nasal cell proliferation in rats exposed to formaldehyde. Toxicol Sci (2003) 1.42
Application of biologically based computer modeling to simple or complex mixtures. Environ Health Perspect (2002) 1.42
Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice. J Exp Clin Cancer Res (2011) 1.38
Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment. Chem Res Toxicol (2011) 1.38
Introducing the external link model for studying spine fixation and misalignment: part 1--need, rationale, and applications. J Manipulative Physiol Ther (2007) 1.38
Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release (2009) 1.38
The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate (2008) 1.38
Schiff base transition metal complexes as novel inhibitors of xanthine oxidase. Eur J Med Chem (2007) 1.36
Modeling interindividual variation in physiological factors used in PBPK models of humans. Crit Rev Toxicol (2003) 1.36
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res (2008) 1.35
Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J Immunol (2008) 1.34
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. Mol Pharmacol (2006) 1.34
A three-dimensional carbon nanotube/graphene sandwich and its application as electrode in supercapacitors. Adv Mater (2010) 1.31
Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening. Toxicol Sci (2010) 1.30
Modeling regional/urban ozone and particulate matter in Beijing, China. J Air Waste Manag Assoc (2009) 1.29
IVT-seq reveals extreme bias in RNA sequencing. Genome Biol (2014) 1.29
Superlubricity in centimetres-long double-walled carbon nanotubes under ambient conditions. Nat Nanotechnol (2013) 1.28
Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol (2003) 1.28
Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension (2002) 1.28
A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol (2009) 1.25
Artifact and noise suppression in GRAPPA imaging using improved k-space coil calibration and variable density sampling. Magn Reson Med (2005) 1.25
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trial. Clin J Pain (2004) 1.24
Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J Immunol (2004) 1.24
Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J Control Release (2005) 1.24
A modeling study of coarse particulate matter pollution in Beijing: regional source contributions and control implications for the 2008 Summer Olympics. J Air Waste Manag Assoc (2008) 1.24
Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. Toxicol Pathol (2007) 1.24